X-XSS-Protection: 1; mode=block X-Content-Type-Options: nosniff Strict-Transport-Security: max-age=63072000; includeSubDomains; preload

Pipeline

EM Imaging portfolio

Edinburgh Molecular Imaging has a portfolio of agents designed to improve detection and treatment of Cancer. All Agents progressed to date have been found to be safe, specific, sensitive and selective.

Therapy

Indications to be disclosed at a later stage.

PET Imaging

Optical Imaging

EMI-137 (Optical Agent) was previously known as GE-137. See related publications here.